SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Nath Bio-Genes (India) Ltd

BSE: 537291 NSE: NATHBIOGEN ISIN: INE448G01010
  |   Sector:  Agriculture & Allied activities   |   Industry:  Agriculture

Snapshot

Q.1 Which industry/sub-sector does Nath Bio-Genes (India) Ltd belong to?
Nath Bio-Genes (India) Ltd belongs to the Agriculture & Allied activities sector, operating specifically within the Agriculture segment.
Q.2 Is Nath Bio-Genes (India) Ltd a good quality company?
Nath Bio-Genes (India) Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Nath Bio-Genes (India) Ltd undervalued or overvalued?
Nath Bio-Genes (India) Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Nath Bio-Genes (India) Ltd a good buy now?
Nath Bio-Genes (India) Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd revenue growth is 8.9% for FY-2025 , which is above its 5 year CAGR of 5.3% , indicating faster growth.
Q.2 Gross Profit margin of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Gross profit margin which is the profit after deduction of direct costs, is 13.1% for FY-2025 , which is in line with its 5 year median of 13.1% , indicating stable margins.
Q.3 Operating Profit Margin of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 14.75% for FY-2025 , which is below its 5 year median of 15.18% indicating decreasing margins.
Q.4 Net Profit Margin of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Net Profit Margin is 11.63% for FY-2025 , is below with its 5 year median of 11.67%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 13.1 13.1
Operating Profit Margin 14.75 15.18
Net Profit Margin 11.63 11.67
Q.5 Return on Asset of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Return on Asset is 4.45%, which is below its 5 year historical median of 4.59%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Return on equity is 6.69% for FY-2025 , which is in line with its historical median of 6.69%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Return on capital employed is 7.29% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Cash conversion cycle is 299 days, below its historical median of 301 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.38 0.39
ROE 6.69 6.69
ROCE 7.29 7.29
Cash Conversion Cycle 299 days 301 days
Q.9 Debt to Equity ratio of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Debt-to-Equity ratio is 0.17 , which is above with the industry average of 0.13 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Nath Bio-Genes (India) Ltd?
Nath Bio-Genes (India) Ltd Debt to cash flow from operations is 4.15 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Nath Bio-Genes (India) Ltd?
Promoters hold 45.60% of the Nath Bio-Genes (India) Ltd, with 13.78% of their stake pledged, indicating high pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Nath Bio-Genes (India) Ltd vs industry peers?
Nath Bio-Genes (India) Ltd revenue CAGR is 5.30% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 362.3 28.6
Gross Profit 47.4 1.5
Operating Profit 52 2
Net Profit 42 1
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.38 0.5
ROE 6.69 6.69
ROCE 7.29 8.57
Cash Conversion Cycle (days) 299.41 67

Valuation & price assessment

Q.1 Stock return of Nath Bio-Genes (India) Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 5.7% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 5.7% -13.2% 2.3% -
Q.3 Valuation ratios of Nath Bio-Genes (India) Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 6.13 10.38 17.42
Price to Book 0.46 0.98 2.03
Price to Sales 0.73 1.91 2.04
EV to EBITDA 6.8 10.05 12.69

Check more companies

1. Kaveri Seed
2. Venkys India
3. Bombay Super Hybrid
4. AVT Natural Prod
5. Regaal Resources
6. Shri Ahimsa Naturals
7. Freshara Agro Export
8. Mangalam Global Ent
9. Kotyark Industries
10. Nath Bio-Genes
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×